Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
Nadège CordelJasmine FlamentFabienne JouenVannina SetaEmmanuelle Tancrède-BohinCatherine Picard DahanMaria-Polina KonstantinouOlivier DereureGaëlle QuéreuxCatherine ProstChristophe BedaneSébastien DebarbieuxJean-Philippe LacourAnne DompmartinEwa Wierzbicka-HainautIsabelle Bourgault VilladaSaskia Ingen Housz OroPierre VabresMarie-Aleth RichardEmmanuel DelaporteAnne Pham-LedardMarie-Thérèse LecciaNoémie LitrowskiCatherine MichelBrigitte LagrangeMichel D'IncanClaire AbasqSophie Duvert-LehembreAlain DupuyIsabelle AlcarazAnne-Laure Breton-GuitarianFlorian LombartEric EstèveLaurent MachetPascal Del GiudiceMarion FenotThibaut BelmondoFlorence MorinOlivia GuérinJacques BenichouBenoît TressièresPascal Jolynull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
These findings suggest that anti-BP180 antibody ELISA value in combination with clinical markers is helpful in managing the risk of APO, in particular IUGR, in patients with PG.
Keyphrases